Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Hepatitis B surface antibody levels after hexavalent-based versus pentavalent-based infant vaccination schedules
TCTR20240513002Phase 4Completed
- Sponsor
- Mahidol University
- Start
- May 2022
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of DTaP-IPV-Hep B-PRP-T vaccine in hepatitis B (HBV), sponsored by Mahidol University. Started May 2022; status: completed.
02
Drugs
DTaP-IPV-Hep B-PRP-T vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on TCTR20240513002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240513002.